The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning

Schizophrenia Research

Volumn 169, Issue 1-3, 2015, Pages 116-120

  Rodriguez Jimenez, R ^a,b,c   Dompablo, M ^a,b   Bagney, A ^a,b   Santabarbara J ^b,d   Aparicio, A I ^e   Torio, I ^a   Moreno Ortega, M ^a,b   Lopez Anton, R ^b,d   Lobo, A ^b,d   Kern, R S ^f,g   Green, M F ^f,g   Jimenez Arriero, M A ^a,b,c   Santos, J L ^e   Nuechterlein, K H ^f,h   Palomo, T ^a,b,c  

^a Universidad Complutense   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d UNIVERSITY OF ZARAGOZA   (Spain)

^e HOSPITAL VIRGEN DE LA LUZ   (Spain)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Age; Cognition; Gender; MATRICS; MCCB; Schizophrenia

Indexed keywords

ADULT; ALERTNESS; ARTICLE; COGNITIVE FUNCTION TEST; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC REASONING; DSM-IV; FEMALE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MATRICS CONSENSUS COGNITIVE BATTERY; PRIORITY JOURNAL; PROBLEM SOLVING; SCHIZOPHRENIA; SOCIAL COGNITION; SPAIN; TASK PERFORMANCE; WORKING MEMORY; ADOLESCENT; AGING; COGNITION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; SEXUAL DEVELOPMENT; YOUNG ADULT;

ADOLESCENT; ADULT; AGING; COGNITION; CROSS-SECTIONAL STUDIES; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX CHARACTERISTICS; SPAIN; YOUNG ADULT;

EID: 84953839518     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.09.013     Document Type: Article

References (30)

1. Addington J., Brooks B.L., Addington D. Cognitive functioning in first episode psychosis: initial presentation. Schizophr. Res. 2003, 44:47-56.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-IV 1994, American Psychiatric Association, Washington, DC. 4th edn.
3. Asarnow R.F., MacCrimmon D.J. Residual performance deficit in clinically remitted schizophrenics: a marker of schizophrenia?. J. Abnorm. Psychol. 1978, 87:597-608.
4. Bilder R.M., Goldman R.S., Robinson D., Reiter G., Bell L., Bates J.A., Pappadopulos E., Willson D.F., Alvir J.M., Woerner M.G., Geisler S., Kane J.M., Lieberman J.A. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am. J. Psychiatry 2000, 157:549-559.
5. Bowie C.R., Leung W.W., Reichenberg A., McClure M.M., Patterson T.L., Heaton R.K., Harvey P.D. Predicting schizophrenia patients' real-world behavior with specific neuropsychological and functional capacity measures. Biol. Psychiatry 2008, 63(5):505-511.
6. Cohen J. Statistical Power Analysis for Behavioral Sciences 1977, Academic Press, New York. revised ed.
7. Daselaar S.M., Veltman D.J., Rombouts S.A., Raaijmakers J.G., Jonker C. Aging affects both perceptual and lexical/semantic components of word stem priming: an event-related fMRI study. Neurobiol. Learn. Mem. 2005, 83(3):251-262.
8. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0) 1995, Biometrics Research Department, New York State Psychiatric Institute, New York.
9. Galderisi S., Davidson M., Kahn R.S., Mucci A., Boter H., Gheorghe M.D., Rybakowski J.K., Libiger J., Dollfus S., López-Ibor J.J., Peuskens J., Hranov L.G., Fleischhacker W.W., EUFEST group Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophr. Res. 2009, 115(2-3):104-114.
10. Georgiou-Karistianis N., Tang J., Mehmedbegovic F., Farrow M., Bradshaw J., Sheppard D. Age-related differences in cognitive function using a global local hierarchical paradigm. Brain Res. 2006, 1124(1):86-95.
11. Grady C.L. Cognitive neuroscience of aging. Ann. N. Y. Acad. Sci. 2008, 1124:127-144.
12. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am. J. Psychiatry 1996, 153(3):321-330.
13. Green M.F., Olivier B., Crawley J.N., Penn D.L., Silverstein S. Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophr. Bull. 2005, 31(4):882-887.
14. Harvey P.D. What is the evidence for changes in cognition and functioning over the lifespan in patients with schizophrenia?. J. Clin. Psychiatry 2014, 75(Suppl. 2):34-38.
15. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998, 12:426-445.
16. Hoff A.L., Svetina C., Shields G., Stewart J., DeLisi L.E. Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophr. Res. 2005, 78(1):27-34.
17. Keefe R.S., Fenton W.S. How should DSM-V criteria for schizophrenia include cognitive impairment?. Schizophr. Bull. 2007, 33:912-920.
18. Kern R.S., Gold J.M., Dickinson D., Green M.F., Nuechterlein K.H., Baade L.E., Keefe R.S., Mesholam-Gately R.I., Seidman L.J., Lee C., Sugar C.A., Marder S.R. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study. Schizophr. Res. 2011, 126(1-3):124-131.
19. Kern R.S., Nuechterlein K.H., Green M.F., Baade L.E., Fenton W.S., Gold J.M., Keefe R.S., Mesholam-Gately R., Mintz J., Seidman L.J., Stover E., Marder S.R. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am. J. Psychiatry 2008, 165(2):214-220.
20. Kimura D. Sex hormones influence human cognitive pattern. Neuro Endocrinol. Lett. 2002, 23(Suppl. 4):67-77.
21. Mesholam-Gately R.I., Giuliano A.J., Goff K.P., Faraone S.V., Seidman L.J. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 2009, 23(3):315-336.
22. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., Heaton R.K. Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 2004, 72:29-39.
23. Nuechterlein K.H., Dawson M.E., Gitlin M., Ventura J., Goldstein M.J., Snyder K.S., Yee C.M., Mintz J. Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress. Schizophr. Bull. 1992, 18:387-425.
24. Nuechterlein K.H., Green M.F., Kern R.S., Baade L.E., Barch D.M., Cohen J.D., Essock S., Fenton W.S., Frese F.J., Gold J.M., Goldberg T., Heaton R.K., Keefe R.S., Kraemer H., Mesholam-Gately R., Seidman L.J., Stover E., Weinberger D.R., Young A.S., Zalcman S., Marder S.R. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am. J. Psychiatry 2008, 165(2):203-213.
25. Rajji T.K., Voineskos A.N., Butters M.A., Miranda D., Arenovich T., Menon M., Ismail Z., Kern R.S., Mulsant B.H. Cognitive performance of individuals with schizophrenia across seven decades: a study using the MATRICS consensus cognitive battery. Am. J. Geriatr. Psychiatr. 2013, 21(2):108-118.
26. Reichenberg A. The assessment of neuropsychological functioning in schizophrenia. Dialogues Clin. Neurosci. 2010, 12:383-392.
27. Rodriguez-Jimenez R., Bagney A., Garcia-Navarro C., Aparicio A.I., Lopez-Anton R., Moreno-Ortega M., Jimenez-Arriero M.A., Santos J.L., Lobo A., Kern R.S., Green M.F., Nuechterlein K.H., Palomo T. The MATRICS consensus cognitive battery (MCCB): co-norming and standardization in Spain. Schizophr. Res. 2012, 134(2-3):279-284.
28. Rund B.R., Barder H.E., Evensen J., Haahr U., Hegelstad W.T., Joa I., Johannessen J.O., Langeveld J., Larsen T.K., Melle I., Opjordsmoen S., Rossberg J.I., Simonsen E., Sundet K., Vaglum P., McGlashan T., Friis S. Neurocognition and Duration of Psychosis: A 10-year Follow-up of First-Episode Patients. Schizophr. Bull. 2015.
29. Tolman A.W., Kurtz M.M. Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation. Schizophr. Bull. 2010, 38(2):304-315.
30. Torrey E.F. Studies of individuals with schizophrenia never treated with antipsychotic medication: a review. Schizophr. Res. 2002, 58:101-115.